Purpose Definitive treatment for patients with early-stage non-small cell lung cancer (ES-
NSCLC) is usually well tolerated. Patients with ES-NSCLC and coexisting interstitial lung …

Background Recognizing the rapidly increasing interest and evidence in using metastasis-
directed radiotherapy (MDRT) for oligometastatic disease (OMD), ESTRO and ASTRO …

Purpose: The purpose of this study was to determine whether pulmonary oligometastases
from colorectal cancer have greater radioresistance than that of pulmonary oligometastases …

We sought to quantify contribution of radiomics and SUVmax at PET/CT to predict clinical
outcome in lung cancer patients treated with stereotactic body radiotherapy (SBRT). 150 …

Background The aim of this analysis was to model the effect of local control (LC) on overall
survival (OS) in patients treated with stereotactic body radiotherapy (SBRT) for liver or lung …

Background and purpose To evaluate whether local tumor control probability (TCP) in
stereotactic body radiotherapy (SBRT) varies between lung metastases of different primary …

Introduction Stereotactic body radiation therapy (SBRT) is applied in the oligometastatic
setting to treat liver metastases. However, factors influencing tumor control probability (TCP) …

Background We evaluated a series of oligometastatic colorectal cancer (CRC) patients
treated with stereotactic ablative body radiotherapy (SABR) delivered in all active lung …

Background and purpose Recent studies have postulated that patients undergoing lung
stereotactic body radiotherapy (SBRT) for ultracentral tumors have higher toxicity and …

Purpose Stereotactic ablative radiation therapy (SABR) is increasingly used to treat lung
oligometastases. We set out to determine the safety and efficacy of this approach and to …